Peptide Registry

N-Acetyl Epithalon Amidate

$31.00

  • Contents: N-Acetyl Epithalon Amidate (Ac-Ala-Glu-Asp-Gly-NH₂; dual-modified AEDG tetrapeptide)
  • Form: Lyophilized powder
  • Purity: >99%
Quantity Discount Price
1 - 3 - $31.00
4 - 7 10% $27.90
8 + 18% $25.42
SKU: N/A Category: Brand:

Description

N-Acetyl Epithalon Amidate is a terminally modified analog of Epithalon and pineal neuroendocrine regulation. Together, these modifications protect both termini from the primary enzymatic attack routes, with dual-modified short peptides documented to achieve approximately 9.5-fold half-life improvement over unmodified sequences in biological matrices. Researchers studying specialty research peptide telomere biology and pineal signaling select this form when sustained compound exposure or direct comparison of modified vs unmodified AEDG behavior is the experimental goal.

Chemical Information

  • Chemical Name: N-Acetyl Epithalon Amidate (N-acetylated, C-terminally amidated analog of Epithalon)
  • Also Known As: Ac-Epithalon-NH2; acetylated Epithalon amide
  • Compound Class: Modified synthetic tetrapeptide analog; stability-enhanced derivative of the Khavinson pineal bioregulator Epithalon (AEDG)
  • Sequence: N-acetyl-Ala-Glu-Asp-Gly-amide (N-terminal acetylation and C-terminal amidation of the parent Epithalon sequence)
  • Molecular Formula: Not established in public literature for the modified analog (parent Epithalon: C14H22N4O9)
  • Molecular Weight: Not established in public literature for the modified analog (parent Epithalon: 390.3 g/mol)
  • CAS Number: Not established in public literature for the modified analog (parent Epithalon: 307297-39-8)

Applications

  • Peptide stability and pharmacokinetic modification research. N-terminal acetylation and C-terminal amidation reduce susceptibility to aminopeptidase and carboxypeptidase degradation. This analog is used in comparative research alongside unmodified Epithalon to study how these modifications affect proteolytic stability and functional persistence in cell-based assays
  • Telomerase activity and cellular senescence research. Because the modified analog retains the core Ala-Glu-Asp-Gly sequence responsible for Epithalon’s reported telomerase-activating effects in cultured human cells, it is studied in the same experimental context as the parent compound to determine whether the terminal modifications preserve, enhance, or alter this activity
  • Pineal and circadian signaling research. As a structural analog of the pineal bioregulator Epithalon, researchers use it in exploratory research on pineal gland function and melatonin-linked signaling pathways
  • Note on evidence base: There is very little data specific to this compound. Most mechanistic and efficacy claims are extrapolated from research on unmodified Epithalon. Therefore, researchers should treat analog-specific claims as unverified pending direct study

Storage and Handling

Store lyophilized powder at -20C for long-term stability, or at 2-8C for short-term use. Protect from heat, moisture, and direct light. Store reconstituted solutions refrigerated at 2-8C and use promptly. Avoid repeated freeze-thaw cycles.

Compliance Notice

N-Acetyl Epithalon Amidate is for laboratory research use only. It is not for human or veterinary use and carries no therapeutic, diagnostic, or clinical indication. FDA has not evaluated this product. By purchasing this product, the buyer confirms that they will follow appropriate institutional safety procedures and use it exclusively for controlled research.

Frequently Asked Questions

What is N-Acetyl Epithalon Amidate?

N-Acetyl Epithalon Amidate is a terminally modified form of Epithalon (AEDG) with N-terminal acetylation and C-terminal amidation. These modifications protect both peptide termini from enzymatic degradation, improving metabolic stability approximately 9.5-fold relative to unmodified short peptides in biological matrices. The core AEDG sequence and its telomerase activation and pineal signaling research context are unchanged.

How does N-Acetyl Epithalon Amidate differ from unmodified Epithalon in research design?

The biological target and mechanism are identical — both engage hTERT-mediated telomerase activation and pineal pathway signaling through the same AEDG sequence. The difference is pharmacokinetic: N-Acetyl Epithalon Amidate persists longer in biological systems, making it appropriate for protocols requiring sustained compound exposure and for comparative studies examining how terminal modification affects endpoint measurements against unmodified Epithalon controls.

Is the research evidence-based for N-Acetyl Epithalon Amidate equivalent to Epithalon?

No — the published mechanistic literature is built primarily on unmodified Epithalon. N-Acetyl Epithalon Amidate's research rationale derives from the parent compound literature, combined with established peptide chemistry principles around acetylation and amidation stability. Researchers using this form should reference Epithalon studies for mechanistic context while treating the modified analog as a stability-optimized variant whose specific behavior requires validation in their experimental system.